Answer
Yes. Follow-up assesses recovery, immune function and disease response, and lifelong monitoring is required for possible secondary malignancies.
Sources for this answer
- YESCARTA — Current selected SmPCemc · Summary of Product Characteristics
- UK GovernmentUK Government · Reputable Web
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.